Dr. Mitra’s latest work explores early treatment vs. expectant management for hemodynamically significant PDA in preterm infants (<37 weeksor <2500g). With potential risks from NSAIDs and ongoing debate in neonatal care on PDA management, this Cochrane Review updates existing evidence to guide clinical decision-making.
Learn more:
https://pubmed.ncbi.nlm.nih.gov/40548426/